Arecor CEO on 2025 outlook & oral GLP-1 platform - ICYMI
Arecor Therapeutics PLC (AIM:AREC) CEO Sarah Howell talked with Proactive about the company’s strong progress across its proprietary diabetes and obesity pipeline and partnerships. The discussion followed the release of Arecor Therapeutics’ full-year …